Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Zafi Avnur
AddedFeb 13, 2024
UpdatedMay 31, 2026
Zafi Avnur

Zafi Avnur

Board Member, SQZ Biotechnologies

CrunchbaseThe Org

Zafi Avnur's Career

SQZ Biotechnologies
SQZ Biotechnologies

Watertown, MA, US

Board Member· Board
EnClear Therapies
EnClear Therapies

Cambridge, MA, US

Board Member· Board
PhysIQ
PhysIQ

Naperville, IL, US

Board Member· Board
Variantyx
Variantyx

Framingham, MA, US

Board Member· Board
Lyndra
Lyndra

Watertown, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Zafi Avnur's Career

SQZ Biotechnologies
SQZ Biotechnologies
Public$229.8M1132013Watertown, MA, US
Board Member· Board

Leadership at SQZ Biotechnologies

Garry NicholsonGarry NicholsonBoard Member
Bob LangerBob LangerCo-Founder
Eric MoessingerEric MoessingerBoard Member
Klavs JensenKlavs JensenCo-Founder
Marc EliaMarc EliaBoard Member
Pushkal GargPushkal GargBoard Member
EnClear Therapies
EnClear Therapies
Series A$12M122018Cambridge, MA, US
Board Member· Board

Leadership at EnClear Therapies

Jonathan FlemingJonathan FlemingBoard Member
Anthony DePasquaAnthony DePasquaCEO
Jason CammJason CammBoard Member
Kasper RoetKasper RoetBoard Member
Kevin EgganKevin EgganCo-Founder
Hillel BachrachHillel BachrachBoard Member
PhysIQ
PhysIQ
Pre-Seed$26.4M812011Naperville, IL, US
Board Member· Board

Leadership at PhysIQ

Gary ConkrightGary ConkrightBoard Member
Matt PipkeMatt PipkeCo-Founder
Dan MalvenDan MalvenBoard Member
Edward MichaelEdward MichaelBoard Member

Similar to PhysIQ

VitalFloVitalFloRaleigh, NC, USAnalytics, Medical Devicesest. 2017VitalFloRaleigh, NC, US · est. 2017

VitalFlo: Digital health firm providing remote lung monitoring and predictive analytics for asthmatics.

Seed · $3.8M9
HealthSnapHealthSnapMiami, FL, USDisease Management, Patient Monitoringest. 2015HealthSnapMiami, FL, US · est. 2015

HealthSnap: Remote patient monitoring for effective virtual chronic disease management.

Series A · $21.6M75
PhysiaPhysiaAurora, CO, USHealth Monitoring, Smart Textilesest. 2017PhysiaAurora, CO, US · est. 2017

Physia: A smart textile firm monitoring cardiovascular risk, hydration, temperature, and fall impact to prevent injuries.

Seed · $2.1M3
Prescribe FITPrescribe FITColumbus, OH, USHealth Coaching, Patient Monitoringest. 2017Prescribe FITColumbus, OH, US · est. 2017

Prescribe FIT: A remote patient monitoring company promoting healthy lifestyle adaptation.

Seed · $7.2M25
Variantyx
Variantyx

Framingham, MA, US

Board Member· Board
Lyndra
Lyndra
Series E$284.6M1612015Watertown, MA, US
Board Member· Board

Leadership at Lyndra

Andrew BellingerAndrew BellingerCo-Founder
Patricia HurterPatricia HurterBoard Member
Giovanni TraversoGiovanni TraversoCo-Founder
Robert LangerRobert LangerCo-Founder
Colin GardnerColin GardnerCo-Founder
Catherine B. ReynoldsCatherine B. ReynoldsBoard Member

Similar to Lyndra

Lyra TherapeuticsLyra TherapeuticsWatertown, MA, USDrugs, Therapeuticsest. 2014Lyra TherapeuticsWatertown, MA, US · est. 2014

Lyra Therapeutics, Inc.: A clinical-stage biotech firm innovating localized treatments for chronic rhinosinusitis.

Public · $264.1M66
Lindy BiosciencesLindy BiosciencesDurham, NC, USDrug Deliveryest. 2017Lindy BiosciencesDurham, NC, US · est. 2017

Lindy Biosciences: A development-stage company specializing in protein therapeutic formulations.

Series B · $6.6M11
Lykos TherapeuticsLykos TherapeuticsSan Jose, CA, USPharmaceuticalsest. 2014Lykos TherapeuticsSan Jose, CA, US · est. 2014

Lykos Therapeutics: Revolutionizing mental health with innovative, science-backed psychedelic therapies.

Series A · $100M175
LydexLydexMount Pleasant, SC, USDrug Therapyest. 2017LydexMount Pleasant, SC, US · est. 2017

Lydex Pharmaceuticals: Innovating liver IR therapies for safer surgeries and transplants.

Angel · $50k8

Zafi Avnur's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Zafi Avnur

Mike RossMike RossBoard Member · Therini BioJesse LevinsonJesse LevinsonBoard Member · ZooxMark CargesMark CargesBoard Member · SplunkMichael RoweMichael RoweBoard Member · Hyperion DeFiRyan PhillipsRyan PhillipsBoard Member · AliveCorBob NyeBob NyeBoard Member · DoubleVerify